U.S. agency expected to approve malaria drug
Infection Control Weekly Monitor, December 31, 2008
Want to receive articles like this one in your inbox? Subscribe to Infection Control Weekly Monitor!
The Food and Drug Administration is expected to soon approve the first malaria drug in the United States containing artemisinin, a wormwood derivative from China, reported The New York Times. The newspaper said artemisinin is the latest and much heralded cure for malaria in Africa and Asia.
Although cases of malaria are rate in this country – there are only about 1,500 of cases treated each year, virtually all from people returning from the tropics—the approval would also make the drug available to the military and to Americans traveling abroad, the Times reported. The drug, Coartem, is made by the Swiss company Novartis.
Want to receive articles like this one in your inbox? Subscribe to Infection Control Weekly Monitor!
Comments
0 comments on “U.S. agency expected to approve malaria drug ”
Related Products
-
Patient Safety Monitor
As part of your Patient Safety Monitor membership, you'll receive Briefings on Patient Safety. In this 12-page monthly...
-
Patient Safety Monitor Alert
This e-mail newsletter provides healthcare professionals with the latest patient safety news, while offering useful...
-
Infection Control Weekly Monitor
Infection Control Weekly Monitor keeps you up-to-date on what's happening in the world of infection control. Every issue...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Searched